AGÕæÈ˹ٷ½

STOCK TITAN

[SCHEDULE 13G/A] Precision BioSciences, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Novartis Pharma AG
Signature:/s/ Christian Rehm
Name/Title:Christian Rehm / Authorised Signatory
Date:08/05/2025
Signature:/s/ Lukas Foertsch
Name/Title:Lukas Foertsch / Authorised Signatory
Date:08/05/2025
Novartis AG
Signature:/s/ Christian Rehm
Name/Title:Christian Rehm / Authorised Signatory
Date:08/05/2025
Signature:/s/ Daniel Weiss
Name/Title:Daniel Weiss / Authorised Signatory
Date:08/05/2025
Exhibit Information

Exhibit 1 - Evidence of Signatory Authority

Precision Biosciences

NASDAQ:DTIL

DTIL Rankings

DTIL Latest News

DTIL Latest SEC Filings

DTIL Stock Data

59.05M
10.30M
10.29%
46.23%
10.77%
Biotechnology
Biological Products, (no Disgnostic Substances)
United States
DURHAM